Immunovant Ownership | Who Owns Immunovant?
Immunovant Ownership Summary
Immunovant is owned by 15.02% institutional investors, 57.26% insiders, and 27.72% retail investors. Fmr is the largest institutional shareholder, holding 9.34% of IMVT shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 3.40% of its assets in Immunovant shares.
IMVT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Immunovant | 15.02% | 57.26% | 27.72% |
| Sector | Healthcare Stocks | 35.71% | 11.88% | 52.42% |
| Industry | Biotech Stocks | 35.98% | 11.86% | 52.17% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 16.95M | 9.34% | $420.99M |
| Deep track capital, lp | 11.53M | 6.35% | $286.33M |
| Vanguard group | 7.78M | 4.48% | $197.75M |
| Blackrock funding, inc. /de | 6.57M | 3.62% | $163.31M |
| Blackrock | 4.92M | 3.56% | $129.79M |
| Baker bros. advisors lp | 5.46M | 3.01% | $135.57M |
| State street | 4.54M | 2.50% | $112.72M |
| Tcg crossover management | 4.46M | 2.46% | $110.74M |
| Morgan stanley | 3.88M | 2.14% | $96.30M |
| T. rowe price investment management | 3.61M | 1.99% | $89.74M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Alpine global management | 2.64M | 9.81% | $65.50M |
| Superstring capital management lp | 357.61K | 6.35% | $8.88M |
| Deep track capital, lp | 11.53M | 4.68% | $286.33M |
| Stempoint capital lp | 746.49K | 3.60% | $18.54M |
| Adar1 capital management | 2.24M | 3.39% | $36.14M |
| Tcg crossover management | 4.46M | 3.17% | $110.74M |
| Great point partners | 545.63K | 3.11% | $13.55M |
| Armistice capital | 3.56M | 1.57% | $88.55M |
| Highvista strategies | 225.14K | 1.54% | $5.59M |
| Logos global management lp | 1.07M | 1.33% | $26.70M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tcg crossover management | 4.46M | 3.17% | 2.80M |
| Jennison associates | 3.20M | 0.05% | 2.50M |
| Adar1 capital management | 2.24M | 3.39% | 1.71M |
| Farallon capital management | 1.55M | 0.22% | 1.53M |
| Vanguard group | 7.78M | 0.00% | 952.50K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | 3.56M | 1.57% | -2.18M |
| Point72 asset management | - | - | -2.00M |
| T. rowe price investment management | 3.61M | 0.06% | -1.45M |
| Paradigm biocapital advisors lp | - | - | -1.36M |
| Viking global investors lp | - | - | -1.11M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 637.95K | 0.00% | 637.95K | $15.80M |
| Vanguard fiduciary trust | 544.54K | 0.00% | 544.54K | $13.53M |
| Balyasny asset management | 197.57K | 0.00% | 197.57K | $3.16M |
| Renaissance | 192.50K | 0.01% | 192.50K | $4.78M |
| Dme capital management, lp | 93.52K | 0.07% | 93.52K | $2.32M |
Sold Out
| Holder | Change |
|---|---|
| Reuter james wealth management | -1.00 |
| Dunhill financial | -1.00 |
| Physician wealth advisors | -1.00 |
| Capital performance advisors llp | -3.00 |
| Nelson, van denburg & campbell wealth management group | -11.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 139 | -33.17% | 27,270,250 | -74.89% | 15 | 0.38% | 89 | -22.61% | 21 | -61.11% |
| Dec 31, 2025 | 165 | -16.24% | 62,414,346 | -34.42% | 35 | 1.16% | 93 | -4.12% | 40 | -23.08% |
| Sep 30, 2025 | 191 | 5.52% | 94,495,463 | -1.81% | 55 | 1.74% | 93 | -6.06% | 51 | 2.00% |
| Jun 30, 2025 | 178 | -15.64% | 96,201,301 | 3.59% | 56 | 1.41% | 96 | -25.58% | 50 | 19.05% |
| Mar 31, 2025 | 212 | 2.42% | 94,119,777 | 17.45% | 64 | 2.15% | 130 | 23.81% | 43 | -30.65% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 6.93M | 3.40% | 91.93K |
| Fidelity Growth Compy Commingled Pl O | 4.45M | 3.04% | 196.00K |
| Fidelity Growth Company Fund | 5.10M | 2.51% | 66.50K |
| State Street® SPDR® S&P® Biotech ETF | 2.86M | 1.41% | -28.30K |
| Vanguard Total Stock Mkt Idx Inv | 2.61M | 1.28% | 11.16K |
| Vanguard US Total Market Shares ETF | 2.12M | 1.25% | 2.26K |
| iShares Russell 2000 ETF | 1.91M | 0.94% | 16.12K |
| Vanguard Small Cap Index | 1.87M | 0.92% | -7.89K |
| SPDR® S&P Biotech ETF | 1.30M | 0.74% | 2.90K |
| Fidelity Growth Company K6 | 1.41M | 0.69% | 9.87K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 18, 2026 | Van Tuyl Christopher | Chief Legal Officer | Sell | $93.22K |
| Jun 15, 2026 | Pande Atul | - | Sell | $51.03K |
| May 28, 2026 | Fromkin Andrew J. | - | Sell | $374.81K |
| May 28, 2026 | Fromkin Andrew J. | - | Sell | $7.06M |
| May 20, 2026 | Gloria Melanie | Chief Operating Officer | Sell | $7.57K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 16 |
| 2026 Q1 | - | 7 |
| 2025 Q4 | 1 | 12 |
| 2025 Q3 | - | 4 |
| 2025 Q2 | - | 5 |
IMVT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools